A Study of MBG453 in Combination With Azacitidine and Venetoclax in AML Patients Unfit for Chemotherapy
Clinical trial NCT04150029 · TERMINATED
Trial details
- NCT number
- NCT04150029
- Sponsor
- Novartis Pharmaceuticals
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-09-01
- Primary completion
- 2024-10-25
- Enrollment
- 90
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.